Details
There is a significant void in our understanding of the specific medications utilized by pregnant women with COVID-19 in real-world outpatient settings. Existing evidence refers to small populations or inpatient prescriptions only.
This poster estimates medicines use prevalence by pregnancy trimester in non-hospitalized pregnant women with COVID-19 and compare it with pregnant women without COVID-19 and non-pregnant women with COVID-19. It was presented at the 2024 ISPE Annual Meeting.
Additional Information
Contributors
de Bruin O, Maisonneuve E, Hurley Nordeng, Bérard A, Sheehy O, Kaul P, Shinde MU, Cosgrove A, Lyons JG, Messenger Jones E, Kempner ME, Toh SD, Hua W, Hernández-Muñoz, Sahin L, Cesta CE, Hägg D, Gini R, Paoletti O, Poblador-Plou B, Jordan S, Thayer D, Rodríguez-Bernal CL, Sánchez-Sáez F, Lassalle R, Bernard MA, Alsina E Ahmadizar F, Guillaume F, Panchaud A, Bloemenkamp KWM, Siiskonen SJ, and Sturkenboom